ObeDi: Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Completed
CT.gov ID
NCT01762683
Collaborator
(none)
38
2
3
45.3
19
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to improve the understanding of cellular mecanism involved in delivery disorders in obese women, first by characterizing the hyperplasia phenomenon of myometrail cells induced by inflammatory stimulation (Il-1B), then by studying the role of blood mononuclear cells, of leptine and of obese women sera to interfere with the transition of myometrial cells toward hyperplasia phenotype.

Condition or Disease Intervention/Treatment Phase
  • Other: Myometrium biopsy and blood samples
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
38 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Study of Role of Mononuclear Cells of Maternal Peripheric Blood in Human Myometrial Primar Cell Lines Differentiation Toward a Contratyl Phenotype: Influence of Preconceptional Obesity
Actual Study Start Date :
Apr 6, 2012
Actual Primary Completion Date :
Jan 15, 2016
Actual Study Completion Date :
Jan 15, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: pre-conceptional obesity with a scheduled cesarean section

Other: Myometrium biopsy and blood samples
The biopsy of myometrium is specially realised for the study in surgical unit after the release of the child, in women with normal pregnancy but necessitating a caesarean. The blood samples are realised, specially for the study, either during the medical exam before the ceasarean or specifically for the study.

Active Comparator: non-obese women with a scheduled cesarean section

Other: Myometrium biopsy and blood samples
The biopsy of myometrium is specially realised for the study in surgical unit after the release of the child, in women with normal pregnancy but necessitating a caesarean. The blood samples are realised, specially for the study, either during the medical exam before the ceasarean or specifically for the study.

Active Comparator: women entering labour

women entering labour for vaginal delivery and for vaginal delivery

Other: Myometrium biopsy and blood samples
The biopsy of myometrium is specially realised for the study in surgical unit after the release of the child, in women with normal pregnancy but necessitating a caesarean. The blood samples are realised, specially for the study, either during the medical exam before the ceasarean or specifically for the study.

Outcome Measures

Primary Outcome Measures

  1. Measuring the expression level of markers (Gama actine, Desmine, Connexine-43, and Ocytocine receptor) by Westernblotting [up to 2 months]

    Demonstrate in vitro the capacity of a Il-1B stimulus to induce the differentiation of the myometrial cells toward a hyperplasia phenotype, and that the answer depends on whether this is cells from normal weight women or obese women before conception.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Informed consent signed

  • Patient affiliated with a social security scheme

  • In front of for obstetrical reasons to give birth by caesarean section (scheduled caesarean section)

  • Or a woman who is not obese in labour and needs to undergo a cesarean section

  • No obvious infectious context

  • Age > 18 years old

Exclusion Criteria:
  • Obvious inflammatory or autoimmune diseases

  • Suspected or confirmed infectious context, including virale infection VIH, VHC, VHB

  • Coagulation disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maternité du CHU de Dijon Dijon Bourgogne France 21000
2 Clinique Sainte Marthe Dijon France 21000

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT01762683
Other Study ID Numbers:
  • LIRUSSI-AOI-2011
First Posted:
Jan 8, 2013
Last Update Posted:
Dec 21, 2018
Last Verified:
Jan 1, 2013
Keywords provided by Centre Hospitalier Universitaire Dijon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2018